New Key Statistics Module, Z-Score and F-Score
SZSE:300529 Key Ratios
Market Cap ¥ M | 24,014.06 |
Enterprise Value ¥ M | 22,470.58 |
P/E(ttm) | 30.12 |
PE Ratio without NRI | 29.38 |
Forward PE Ratio | 17.05 |
Price/Book | 7.25 |
Price/Sales | 9.18 |
Price/Free Cash Flow | 27.59 |
Price/Owner Earnings | 51.23 |
Payout Ratio % | 0.39 |
Revenue (TTM) ¥ M | 2,632.00 |
EPS (TTM) ¥ | 0.99 |
Beneish M-Score | -2.45 |
10-y EBITDA Growth Rate % | 23.10 |
5-y EBITDA Growth Rate % | 10.30 |
y-y EBITDA Growth Rate % | 84.50 |
EV-to-EBIT | 22.06 |
EV-to-EBITDA | 22.06 |
PEG | 2.85 |
Shares Outstanding M | 798.61 |
Net Margin (%) | 30.56 |
Operating Margin % | 39.21 |
Pre-tax Margin (%) | 37.11 |
Quick Ratio | 3.41 |
Current Ratio | 3.77 |
ROA % (ttm) | 14.39 |
ROE % (ttm) | 25.43 |
ROIC % (ttm) | 31.52 |
Dividend Yield % | 1.36 |
Altman Z-Score | 8.49 |
SZSE:300529 Number of Guru Trades
SZSE:300529 Volume of Guru Trades
Gurus Latest Trades with SZSE:300529
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
SZSE:300529 is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Jafron Biomedical Co Ltd Insider Transactions
No Available Data